using the case study of atezolizumab development to rethink early phase oncology trial design
Published 1 year ago • 142 plays • Length 52:35Download video MP4
Download video MP3
Similar videos
-
23:25
learn about cancer immunotherapy clinical trials – nyc immunotherapy patient summit 2018
-
6:06
atezolizumab monotherapy vs docetaxel in 2nd and 3rd line nsclc
-
6:20
atezolizumab for locally advanced or metastatic pd-l1-selected nsclc
-
58:37
finding clinical trials for metastatic breast cancer
-
20:23
phase i clinical trials overview | dana-farber cancer institute
-
58:21
what can you expect from a lung cancer clinical trial
-
49:13
clinical trials 101
-
56:27
ccf webinar: a clinical trial for a potential new ther2apy for biliary tract cancers
-
46:10
designing clinical trials for precision oncology. 262
-
4:34
modern methods of phase 1 clinical trial design
-
24:38
clinical trial design & development of highly targeted agents in the molecular era
-
14:16
phase ii clinical trial development for tivatinib (arq 197) in gi cancers
-
4:44
phases of cancer clinical trials – an introduction, with neal meropol, md
-
57:32
mutational analysis and clinical trial design in cancer therpeutics
-
32:05
clinical trials and cancer immunotherapy: accessing promising treatments
-
39:10
the changing nature of phase i trials
-
4:31
impower130: pfs and safety of adding atezolizumab to first-line nsclc therapy
-
3:30
princeps study: atezolizumab for resectable nsclc
-
3:52
understanding gynecologic cancer clinical trials